{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:43:57Z","timestamp":1792683837783,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007330","name":"AtriCure Inc","doi-asserted-by":"publisher","award":["010-0004A"],"award-info":[{"award-number":["010-0004A"]}],"id":[{"id":"10.13039\/100007330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005747","name":"AP M\u00f8ller and Chastine McKinney M\u00f8ller Foundation","doi-asserted-by":"publisher","award":["L-2022-00260"],"award-info":[{"award-number":["L-2022-00260"]}],"id":[{"id":"10.13039\/501100005747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020035","name":"A. P. M\u00f8llerske St\u00f8ttefond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ahj.2025.04.015","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T13:53:37Z","timestamp":1744725217000},"page":"86-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Rationale and design of the anticoagulant therapy after left atrial appendage closure (ATLAAC) trial"],"prefix":"10.1016","volume":"287","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6699-355X","authenticated-orcid":false,"given":"Kristina","family":"Gosvig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Goller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils Henrik","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Brandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy","family":"Modrau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise Feilberg","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Eskesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aksel Karl Georg","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Belley-C\u00f4t\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Whitlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Peter Sch\u00f8dt","family":"Riber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2025.04.015_bib0001","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","article-title":"Atrial fibrillation as an independent risk factor for stroke: the Framingham Study","volume":"22","author":"Wolf","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2025.04.015_bib0002","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2025.04.015_bib0003","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2025.04.015_bib0004","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2025.04.015_bib0005","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jama.2017.20125","article-title":"Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing concomitant cardiac surgery","volume":"319","author":"Friedman","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2025.04.015_bib0006","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2025.04.015_bib0007","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/CIRCULATIONAHA.122.060315","article-title":"Oral anticoagulation use and left atrial appendage occlusion in LAAOS III","volume":"148","author":"Connolly","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2025.04.015_bib0008","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4330\/wjc.v10.i11.242","article-title":"Surgical left atrial appendage occlusion during cardiac surgery: a systematic review and meta-analysis","volume":"10","author":"Atti","year":"2018","journal-title":"World J Cardiol"},{"key":"10.1016\/j.ahj.2025.04.015_bib0009","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.athoracsur.2024.01.007","article-title":"The Society of Thoracic Surgeons 2023 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation","volume":"118","author":"Wyler von Ballmoos","year":"2024","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.ahj.2025.04.015_bib0010","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(91)90585-W","article-title":"Canadian Atrial Fibrillation Anticoagulation (CAFA) Study","volume":"18","author":"Connolly","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2025.04.015_bib0011","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2025.04.015_bib0012","first-page":"687","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2025.04.015_bib0013","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1016\/j.jacc.2013.01.061","volume":"61","author":"Alli","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2025.04.015_bib0014","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1001\/archinte.1991.00400100032005","article-title":"The impact of long-term warfarin therapy on quality of life. Evidence from a randomized trial. Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators","volume":"151","author":"Lancaster","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2025.04.015_bib0015","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non\u2010surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ahj.2025.04.015_bib0016","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1016\/j.ijcard.2012.06.025","article-title":"Validity and reliability of three commonly used quality of life measures in a large European population of coronary heart disease patients","volume":"167","author":"De Smedt","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2025.04.015_bib0017","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-2-12","article-title":"Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease","volume":"2","author":"Atkinson","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ahj.2025.04.015_bib0018","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1477-7525-10-120","article-title":"The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients","volume":"10","author":"Cano","year":"2012","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ahj.2025.04.015_bib0019","series-title":"Sample size calculations in clinical research","author":"Chow","year":"2017"},{"key":"10.1016\/j.ahj.2025.04.015_bib0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2025.04.015_bib0021","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2025.04.015_bib0022","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2025.04.015_bib0023","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2025.04.015_bib0024","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2025.04.015_bib0025","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2025.04.015_bib0026","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jama.1949.02900440011003","article-title":"Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli","volume":"140","author":"Madden","year":"1949","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ahj.2025.04.015_bib0027","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijcard.2016.06.041","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"219","author":"Belgaid","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2025.04.015_bib0028","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1080\/07853890.2021.1968031","article-title":"Adherence to oral anticoagulation in ischemic stroke patients with atrial fibrillation","volume":"53","author":"Tiili","year":"2021","journal-title":"Ann Med"},{"key":"10.1016\/j.ahj.2025.04.015_bib0029","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2025.04.015_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2025.04.015_bib0031","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/CIRCULATIONAHA.118.036248","article-title":"Major bleeding rates in atrial fibrillation patients on single, dual, or triple antithrombotic therapy","volume":"139","author":"van Rein","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2025.04.015_bib0032","doi-asserted-by":"crossref","unstructured":"Wazni OM, Saliba WI, Nair DG, Marijon E, Schmidt B, Hounshell T, et al., Left atrial appendage closure after ablation for atrial fibrillation, New Eng J Med. doi:10.1056\/NEJMoa2408308","DOI":"10.1056\/NEJMoa2408308"},{"key":"10.1016\/j.ahj.2025.04.015_bib0033","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1016\/j.jacc.2022.01.056","article-title":"Primary composite outcome in PRAGUE-17: an unintended butterfly effect","volume":"79","author":"Kim","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2025.04.015_bib0034","doi-asserted-by":"crossref","first-page":"e499","DOI":"10.1016\/j.jacc.2022.04.025","article-title":"Reply: primary composite outcome in PRAGUE-17: an unintended butterfly effect","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2025.04.015_bib0035","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.jacc.2016.10.005","article-title":"Anticoagulant-related bleeding and mortality","volume":"68","author":"Connolly","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2025.04.015_bib0036","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.amjcard.2017.02.015","volume":"119","author":"Steinberg","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2025.04.015_bib0037","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1182\/bloodadvances.2020003560","article-title":"Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry","volume":"5","author":"Bassand","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.ahj.2025.04.015_bib0038","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa055443","article-title":"Comparison of fondaparinux and enoxaparin in acute coronary syndromes","volume":"354","author":"Yusuf","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2025.04.015_bib0039","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2025.04.015_bib0040","unstructured":"European Medicines Agency, Guideline on the choice of the non-inferiority margin:2005. Available from: https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-choice-non-inferiority-margin_en.pdf [accessed 10 January 2025]."},{"key":"10.1016\/j.ahj.2025.04.015_bib0041","unstructured":"U.S. Food and Drug Administration, Non-inferiority clinical trials to establish effectiveness\u2014guidance for industry; 2016. Available from: https:\/\/www.fda.gov\/media\/78504\/download [accessed 10 January 2025]."},{"key":"10.1016\/j.ahj.2025.04.015_bib0042","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ahj.2022.05.003","article-title":"Comparison of anticoagulation with left atrial appendage closure after atrial fibrillation ablation: Rationale and design of the OPTION randomized trial","volume":"251","author":"Wazni","year":"2022","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2025.04.015_bib0043","article-title":"The left atrial appendage exclusion for prophylactic stroke reduction (leaaps) trial: rationale and design","author":"Whitlock","year":"2024","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2025.04.015_bib0044","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ahj.2023.06.003","volume":"264","author":"Madsen","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2025.04.015_bib0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ahj.2021.03.014","article-title":"A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery\u2013\u2013LAA-CLOSURE trial protocol","volume":"237","author":"Kiviniemi","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2025.04.015_bib0046","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/15569845231163857","article-title":"Thoracoscopic left atrial appendage exclusion for atrial fibrillation patients intolerant to anticoagulation","volume":"18","author":"Sharaf","year":"2023","journal-title":"Innovations"},{"key":"10.1016\/j.ahj.2025.04.015_bib0047","first-page":"893","article-title":"Thoracoscopic left atrial appendage clipping: a multicenter cohort analysis","volume":"4","author":"van Laar","year":"2018","journal-title":"JACC: Clin Electrophysiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325001310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870325001310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T09:59:45Z","timestamp":1762077585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870325001310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":47,"alternative-id":["S0002870325001310"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2025.04.015","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale and design of the anticoagulant therapy after left atrial appendage closure (ATLAAC) trial","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2025.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}